| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.05 |